Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SIGA
SIGA Technologies Inc.
stock NASDAQ

At Close
Oct 17, 2025 3:59:57 PM EDT
8.30USD-0.599%(-0.05)281,315
0.00Bid   0.00Ask   0.00Spread
Pre-market
Oct 16, 2025 8:35:30 AM EDT
8.42USD+0.838%(+0.07)0
After-hours
Oct 17, 2025 4:51:30 PM EDT
8.44USD+1.687%(+0.14)400
OverviewOption ChainMax PainOptionsPrice & VolumeDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
07:35AM EST  SIGA Announces Preclinical Oncology Research Collaboration With Bioarchitech   Benzinga
07:30AM EST  SIGA Announces Preclinical Oncology Research Collaboration with   GlobeNewswire Inc
Jan 18, 2022
07:30AM EST  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced today that it will be participating in Edison Groups Open House Event, scheduled to take place virtually this month. SIGA Chief Executive Officer, Phil Gomez, will be presenting and will be available for 1x1 meetings.   GlobeNewswire Inc
Jan 10, 2022
07:49AM EST  SIGA Technologies Receives Approval From European Medicines Agency For Tecovirimat   Benzinga
07:30AM EST  SIGA Technologies Receives Approval from the European Medicines   GlobeNewswire Inc
Dec 1, 2021
09:55AM EST  SIGA Announces Health Canada Regulatory Approval   GlobeNewswire Inc
Nov 17, 2021
11:04AM EST  CDC Says Collaborating With Maryland Department Of Health To Investigate A Case Of Monkeypox In A Traveler Who Returned To U.S. From Nigeria. BZ NOTE: SIGA Technologies Is Working On A Monkeypox Vaccine   Benzinga
11:02AM EST  CDC Says Collaborating With Maryland Department Of Health To Investigate A Case Of Monkeypox In A Traveler Who Returned To U.S. From Nigeria   Benzinga
Nov 16, 2021
08:33AM EST  SIGA Technologies Announces European Medicines Agency Committee For Medicinal Products For Human Use (CHMP) Recommends Approval Of Tecovirimat   Benzinga
08:30AM EST  - Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications -   GlobeNewswire Inc
Nov 5, 2021
09:31AM EDT  SIGA Technologies Q3 EPS $(0.04) Down From $0.31 YoY, Sales $4.80M Down From $44.26M YoY   Benzinga
Nov 4, 2021
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Sep 15, 2021
11:10AM EDT  SIGA Technologies Wins Department Of Defense Contract; Size Not Disclosed   Benzinga
Sep 13, 2021
07:35AM EDT  SIGA Announces BARDA Exercise Of Procurement Option Valued At $112.5M For Oral TPOXX   Benzinga
07:30AM EDT  SIGA Announces BARDA Exercise of Procurement Option Valued at $112   GlobeNewswire Inc
Sep 7, 2021
01:17PM EDT  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Companys Chief Executive Officer, will be a speaker at the NCT USA conference on September 8, in Baltimore, Maryland.   GlobeNewswire Inc
Aug 5, 2021
05:45PM EDT  SIGA Technologies Q2 Sales $8.70M Down From $40.35M YoY   Benzinga
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 29, 2021
10:02AM EDT  SIGA Earlier Announced Collaboration With Oxford University To Support Expanded Access Protocol For Use Of TPOXX (Tecovirimat) To Treat Monkeypox In Central African Republic   Benzinga
03:30AM EDT  SIGA Announces Collaboration with Oxford University to Support   GlobeNewswire Inc
Jul 19, 2021
10:25AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Jun 30, 2021
07:31AM EDT  SIGA Supplies TPOXX as Compassionate Treatment for Monkeypox Case in the United Kingdom   Benzinga
07:30AM EDT  SIGA Supplies TPOXX (Tecovirimat) as Compassionate   GlobeNewswire Inc
May 24, 2021
09:50AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
May 6, 2021
05:14PM EDT  SIGA Technologies Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $4.80M Up From $2.62M YoY   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 4, 2021
07:58AM EDT  SIGA Technologies Files NDA With FDA For Intravenous Formulation Of TPOXX   RTTNews
07:35AM EDT  SIGA Announces New Drug Application Filing With FDA For Intravenous Formulation Of TPOXX   Benzinga
07:30AM EDT  SIGA Announces New Drug Application Filing with FDA for   GlobeNewswire Inc
Apr 29, 2021
08:01AM EDT  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at4:30 P.M. ETonThursday, May 6, 2021. Participating on the call will be Dr.Phil Gomez, Chief Executive Officer andDaniel Luckshire, Chief Financial Officer.   GlobeNewswire Inc
Mar 29, 2021
10:04AM EDT  A Look Into Healthcare Sector Value Stocks   Benzinga
Mar 23, 2021
08:02AM EDT  SIGA Technologies Reports Strategic Partnership With Cipla Therapeutics' USA Unit To Deliver Sustained Innovation, Access To Novel Antibacterial Drugs   Benzinga
08:00AM EDT  Cipla Therapeutics and SIGA Technologies Announce Strategic   GlobeNewswire Inc
Mar 4, 2021
04:08PM EST  SIGA Technologies Q4 EPS $0.26 Up From $(0.06) YoY, Sales $37.80M Up From $4.26M YoY   Benzinga
04:05PM EST  - Approximately 363,000 Courses of Oral TPOXX Delivered to U.S. Government in 2020   GlobeNewswire Inc
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Feb 26, 2021
07:30AM EST  SIGA Technologies to Host Business Update Call on March 4, 2021   GlobeNewswire Inc
Feb 23, 2021
09:10AM EST  SIGA Technologies 13D Shows 4.0% Active Stake From Andrew L. Sole   Benzinga
Jan 13, 2021
04:47PM EST  SIGA Technologies Shares Spike Higher; Co Announces Public Health Agency Of Canada Contract Award To Purchase Up To ~$33M Of Oral TPOXX   Benzinga
04:45PM EST  Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX   GlobeNewswire Inc
Nov 12, 2020
04:05PM EST  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Dennis Hruby, Chief Scientific Officer, will participate in a panel discussion at the Non-Conventional Threats (NCT) Asia Virtual Conference.   GlobeNewswire Inc
Nov 5, 2020
04:50PM EST  SIGA Technologies Q3 EPS $0.31 Up From $(0.03) YoY, Sales $44.30M Up From $8.10M YoY   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Oct 29, 2020
07:30AM EDT  SIGA Technologies to Host Business Update Call on November 5, 2020   GlobeNewswire Inc
Oct 8, 2020
07:33AM EDT  SIGA Announces Public Health Agency of Canada Intent to Purchase Up To 33,300 Courses of Oral TPOXX; Delivery of 18,500 Courses by March 31, 2023; Delivery of Additional 14,800 Courses Subject to Option Exercise   Benzinga
07:30AM EDT  -- Public Health Agency of Canada Contract would be Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX -- Delivery of 18,500 Coursesby March 31, 2023; Delivery of Additional 14,800 CoursesSubject to Option Exercise   GlobeNewswire Inc
Sep 10, 2020
08:30AM EDT  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGAs Chief Executive Officer, will participate in a fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference at 8:00 a.m. ET on Thursday, September 17, 2020.   GlobeNewswire Inc
Aug 31, 2020
07:30AM EDT  Dr. Dennis Hruby Wins 2021 ASM Award for Applied and   GlobeNewswire Inc
Aug 6, 2020
04:55PM EDT  SIGA Technologies Q2 EPS $0.25 Up From $(0.05) YoY, Sales $40.35M Up From $3.91M YoY   Benzinga
Jul 30, 2020
09:06AM EDT  SIGA Earlier Announced Marketing Authorization Filing For Oral Tecovirimat With European Medicines Agency For Multiple Indications   Benzinga
07:30AM EDT  - Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications -   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC